Divestment
Argenx
Argenx is a global immunology company developing antibody-based therapies, with a primary focus on treating severe autoimmune diseases.
Key Facts
- Sector
Life Sciences
- Country
Netherlands
- Fund
LSP 4
- Entry
2009
- Exit
2017
Divestment
Argenx is a global immunology company developing antibody-based therapies, with a primary focus on treating severe autoimmune diseases.
Life Sciences
Netherlands
LSP 4
2009
2017
